ciprofloxacin has been researched along with sulbactam in 43 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (4.65) | 18.7374 |
1990's | 9 (20.93) | 18.2507 |
2000's | 10 (23.26) | 29.6817 |
2010's | 19 (44.19) | 24.3611 |
2020's | 3 (6.98) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Bauraing, C; Bogaerts, P; Cuzon, G; Deplano, A; Glupczynski, Y; Lissoir, B; Naas, T; Nordmann, P | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, JY; Ko, KS; Lee, MY; Park, YK; Peck, KR; Rhee, JY; Shin, JY; Song, JH | 1 |
Chang, FY; Chen, TL; Fung, CP; Huang, LY; Lu, PL; Siu, LK | 1 |
Chang, FY; Chen, TL; Fung, CP; Hsueh, PR; Ko, WC; Kuo, SC; Lee, YT; Siu, LK | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR; Sinn, LM | 1 |
Archambaud, M; Clave, D; Labau, E; Suc, C | 1 |
Hussar, DA | 1 |
Melonakos, TK | 1 |
Miller, LA; Poupard, JA; Rittenhouse, SF; Utrup, LJ | 1 |
Andriole, VT; Dembry, LM; Farrel, PA; Gerrity, LA; Orcutt, DR | 1 |
Falagas, ME; McDermott, L; Snydman, DR | 1 |
Canawati, HN; Montgomerie, JZ; Schick, DG | 1 |
Grudinina, SA; Krotova, LA; Rezvan, SP; Sidorenko, SV; Sterkhova, GV | 1 |
Cisterna, R; Fresnadillo, MJ; García-Rodríguez, JA; Gobernado, M; Martín, R; Perea, E; Picazo, J | 1 |
Akman, M; Arseven, O; Aydin Tosun, G; Erelel, M; Erk, M; Göylüsün, V; Gür, A; Ilvan, A; Koşar, F; Müsellim, B; Oztürk, S; Soysal, F; Türker, H; Tutluoglu, B; Umut, S; Unutmaz, S; Vahapoglu, H; Yildirim, N; Yilmaz Kuyucu, T; Yilmaz, N | 1 |
Hu, DC; Jowell, PS; Killenberg, PG; McGrath, KM | 1 |
Calvo, A; García, R; Gómez-Lus, ML; Leturia, A; Sevillano, D; Valero, E | 1 |
Dudzevicius, V; Sakalauskas, R; Vitkauskiene, A | 1 |
Liu, J; Meng, QG; Wang, Q | 1 |
Chadha, R; Jain, DV; Kashid, N | 1 |
Pang, XY; Tian, BW; Yang, YJ | 1 |
Hashikita, G; Kawakami, S; Kobayashi, S; Maesaki, S; Nagasawa, M; Okabe, T; Sasaki, K; Shibuya, S; Suzuki, N; Takayama, S; Uchida, T; Watanabe, M; Yamaguchi, T | 1 |
Chen, CL; Chia, JH; Chiu, CH; Lee, HY; Liu, SY; Su, LH; Tseng, LY | 1 |
Blahut, L; Hricová, K; Kolár, M; Neiser, J; Urbánek, K; Uvízl, R; Vojtová, V | 1 |
Ari, S; Dal, T; Dayan, S; Dursun, B; Kaya, S; Kortak, MZ; Tekin, R | 1 |
Abdel-Aziz, M; Bräse, S; El-Sheref, EM; Hassan, AA; Ibrahim, YR; Nieger, M | 1 |
Bao, Y; Cai, Y; Chai, T; Gao, J; Li, X; Ma, R; Zhao, X; Zhou, Y | 1 |
Bekeredjian-Ding, I; Gravius, S; Hischebeth, GT; Kohlhof, H; Randau, TM; Wimmer, MD | 1 |
Abdelsalam, M; Abu-Elala, N; Marouf, Sh; Setta, A | 1 |
Badal, RE; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S | 1 |
Aksaray, S; Avcıküçük, H; Başustaoğlu, A; Kaşkatepe, B; Süzük, S | 1 |
Badía, M; Cassini, E; Córdova, E; Gómez, N; López Moral, L; Morganti, L; Rodríguez, C | 1 |
Araújo, MC; De Resende, EA; Lazo-Chica, JE; Miguel, CB; Nogueira, AP; Oliveira, CJ; Paulino, Tde P; Rodrigues, WF; Soares, Sde C; Ueira-Vieira, C | 1 |
Carvalheira, A; Casquete, R; Silva, J; Teixeira, P | 1 |
Harrer, T; Schliep, S; Schuler, G; Simon, M; Tajmir-Riahi, A; Wörl, P | 1 |
Ejaz, A; Ejaz, H; Javed, H; Saleem, R; Younas, S; Zafar, A | 1 |
Borges-Mateus, LM; Carmona-Cartaya, Y; González-Molina, MK; Hidalgo-Benito, M; Pereda-Novales, N; Quiñones-Pérez, D | 1 |
Hu, S; Lou, Z; Shen, Y; Tu, M | 1 |
Choi, HJ; Choi, JY; Choi, YH; Kim, C; Park, RW; Rhie, SJ | 1 |
1 review(s) available for ciprofloxacin and sulbactam
Article | Year |
---|---|
Bacteriological Studies of Venomous Snakebite Wounds in Hangzhou, Southeast China.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteria; Cefazolin; Cefoxitin; Ciprofloxacin; Clavulanic Acid; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Snake Bites; Sulbactam; Venoms | 2022 |
1 trial(s) available for ciprofloxacin and sulbactam
Article | Year |
---|---|
Determination of the etiological organism during acute exacerbations of COPD and efficacy of azithromycin, ampicillin-sulbactam, ciprofloxacin and cefaclor. Turkish Thoracic Society COPD Working Group.
Topics: Ampicillin; Anti-Infective Agents; Azithromycin; Cefaclor; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Sulbactam; Treatment Outcome | 1999 |
41 other study(ies) available for ciprofloxacin and sulbactam
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Carbapenem-resistant Acinetobacter baumannii isolates expressing the blaOXA-23 gene associated with ISAba4 in Belgium.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Belgium; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Transposable Elements; Genes, Bacterial; Humans | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea.
Topics: Aged; beta-Lactamases; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Klebsiella Infections; Klebsiella pneumoniae; Male; Renal Dialysis; Republic of Korea | 2010 |
Molecular characterization of beta-lactamase genes and their genetic structures in Acinetobacter genospecies 3 isolates in Taiwan.
Topics: Acinetobacter; Acinetobacter Infections; beta-Lactam Resistance; beta-Lactamases; Cephalosporinase; Gene Transfer, Horizontal; Genes, Bacterial; Humans; In Vitro Techniques; Integrons; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Phylogeny; Taiwan | 2010 |
Emergence and Distribution of Plasmids Bearing the blaOXA-51-like gene with an upstream ISAba1 in carbapenem-resistant Acinetobacter baumannii isolates in Taiwan.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; Blotting, Southern; Carbapenems; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Molecular Sequence Data; Plasmids; Taiwan | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Cefoperazone; Ciprofloxacin; Clindamycin; Clostridium Infections; Clostridium perfringens; Drug Therapy, Combination; Female; Metronidazole; Microbial Sensitivity Tests; Penicillin G; Peptostreptococcus; Prevotella melaninogenica; Rabbits; Sulbactam | 1990 |
[Bactericidal effect of cefotaxime-sulbactam and imipenem combined with gentamicin and/or ciprofloxacin against CTX-1 producing Klebsiella pneumoniae].
Topics: Cefotaxime; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Gentamicins; Imipenem; Klebsiella pneumoniae; Sulbactam | 1989 |
New drugs of 1987.
Topics: Ampicillin; Aztreonam; Ciprofloxacin; Humans; Sulbactam; United States; United States Food and Drug Administration | 1988 |
Ciprofloxacin-ampicillin sulbactam incompatibility.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Chemistry, Pharmaceutical; Ciprofloxacin; Crystallization; Drug Incompatibility; Penicillins; Sulbactam | 1996 |
Evaluation of 500 gram negative isolates to determine the number of major susceptibility interpretation discrepancies between the Vitek and MicroScan Walkaway for 9 antimicrobial agents.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Enterobacter; Escherichia coli; Imipenem; Klebsiella pneumoniae; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin; Penicillins; Piperacillin; Proteus mirabilis; Pseudomonas aeruginosa; Quality Control; Reproducibility of Results; Sulbactam; Thienamycins; Ticarcillin | 1996 |
In-vitro activity of trovafloxacin against sensitive and resistant aerobic bacteria using the standard microdilution broth method and Etest.
Topics: Ampicillin; Anti-Infective Agents; Bacteria, Aerobic; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Fluoroquinolones; Gentamicins; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Sulbactam; Vancomycin | 1997 |
Effect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteroides fragilis; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Fluoroquinolones; Hydrogen-Ion Concentration; Imipenem; Meropenem; Microbial Sensitivity Tests; Naphthyridines; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Thienamycins | 1997 |
In vitro activity of the combination of trovafloxacin and other antibiotics against enterococci.
Topics: Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterococcus; Enterococcus faecalis; Fluoroquinolones; Gentamicins; Humans; Microbial Sensitivity Tests; Naphthyridines; Novobiocin; Rifampin; Sulbactam; Teicoplanin; Vancomycin | 1997 |
[Multicenter trial of Enterococcus antibiotic susceptibility].
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Gentamicins; Microbial Sensitivity Tests; Moscow; Penicillins; Russia; Streptomycin; Sulbactam; Vancomycin | 1998 |
[Ampicillin-sulbactam activity against respiratory isolates of Haemophilus influenzae].
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cefuroxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Penicillins; Respiratory Tract Infections; Sulbactam | 1998 |
Phlegmonous gastritis: successful treatment with antibiotics and resolution documented by EUS.
Topics: Adult; Ampicillin; Biopsy, Needle; Cellulitis; Ciprofloxacin; Drug Therapy, Combination; Endosonography; Female; Follow-Up Studies; Gastritis; Gastroscopy; Humans; Infusions, Intravenous; Sulbactam; Tomography, X-Ray Computed; Treatment Outcome | 2000 |
[Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii].
Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Infective Agents; Aza Compounds; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Moxifloxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Opportunistic Infections; Quinolines; Sulbactam; Thienamycins | 2001 |
[The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bronchoalveolar Lavage Fluid; Ceftazidime; Cefuroxime; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fusidic Acid; Gentamicins; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Staphylococcus aureus; Sulbactam; Vancomycin Resistance | 2003 |
[Synthesis and in vitro antibacterial activities of new 3,5-disubstituted oxazolidinone compounds].
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Staphylococcus aureus; Streptococcus; Structure-Activity Relationship; Sulbactam; Vancomycin | 2003 |
Microcalorimetric evaluation of the in vitro compatibility of amoxicillin/clavulanic acid and ampicillin/sulbactam with ciprofloxacin.
Topics: Algorithms; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Buffers; Calorimetry; Ciprofloxacin; Drug Incompatibility; Drug Therapy, Combination; Hydrogen-Ion Concentration; Penicillins; Solutions; Sulbactam; Thermodynamics | 2004 |
[Dynamic analysis of drug resistance of Pseudomonas aeruginosa in laboratory and clinical two-drug regimen].
Topics: Amikacin; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam; Tazobactam | 2005 |
[The combination effects of antibacterial agents against clinical isolated multiple-drug resistant Pseudomonas aeruginosa].
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefepime; Cefoperazone; Cephalosporins; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Meropenem; Microbial Sensitivity Tests; Oxazines; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Tazobactam; Thienamycins | 2006 |
Mechanisms of resistance to ciprofloxacin, ampicillin/sulbactam and imipenem in Acinetobacter baumannii clinical isolates in Taiwan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Gene Expression; Humans; Imipenem; Integrons; Point Mutation; Polymerase Chain Reaction; Sequence Analysis, DNA; Sulbactam; Taiwan | 2010 |
Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units.
Topics: Amikacin; Anti-Bacterial Agents; Cefoperazone; Ceftazidime; Ciprofloxacin; Czech Republic; Drug Resistance, Multiple, Bacterial; Gentamicins; Intensive Care Units; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Tazobactam | 2011 |
Evaluation of cutaneous palpebral anthrax.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Cefazolin; Child; Child, Preschool; Ciprofloxacin; Eye; Female; Humans; Infant; Male; Middle Aged; Penicillins; Skin Diseases, Bacterial; Sulbactam; Young Adult | 2013 |
Synthesis and antibacterial activity of 4-aryl-2-(1-substituted ethylidene)thiazoles.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Crystallography, X-Ray; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Sulbactam; Thiazoles | 2013 |
Antibiotic resistance and OXA-type carbapenemases-encoding genes in airborne Acinetobacter baumannii isolated from burn wards.
Topics: Acinetobacter baumannii; Air Microbiology; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Burn Units; Carbapenems; Cefoperazone; Ceftriaxone; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Repetitive Sequences, Nucleic Acid; Sulbactam | 2014 |
Detection of Pantoea agglomerans in hip prosthetic infection by sonication of the removed prosthesis: the first reported case.
Topics: Administration, Intravenous; Administration, Oral; Ampicillin; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Ciprofloxacin; Female; Hip Prosthesis; Humans; Middle Aged; Osteoarthritis, Hip; Pantoea; Postoperative Complications; Prosthesis-Related Infections; Sonication; Sulbactam | 2013 |
Comparative analysis of virulence genes, antibiotic resistance and gyrB-based phylogeny of motile Aeromonas species isolates from Nile tilapia and domestic fowl.
Topics: Aeromonas caviae; Aeromonas hydrophila; Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Chickens; Cichlids; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Feces; Fish Diseases; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Polymerase Chain Reaction; Poultry Diseases; Sulbactam; Virulence Factors | 2015 |
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; China; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Gene Expression; Humans; Imipenem; Intraabdominal Infections; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2016 |
[The comparison of antibiotic susceptibilities of uropathogenic Escherichia coli isolates in transition from CLSI to EUCAST].
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Cefuroxime; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Escherichia coli Infections; European Union; Gentamicins; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Reference Standards; Sulbactam; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey; Urinary Tract Infections; Uropathogenic Escherichia coli | 2015 |
[Antimicrobial susceptibility of Gram-negative bacilli of community acquired intra-abdominal infections in a hospital at Buenos Aires, Argentina].
Topics: Abdomen; Adolescent; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Argentina; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Sulbactam; Young Adult | 2016 |
Antibiotic Resistance of Bacteria Involved in Urinary Infections in Brazil: A Cross-Sectional and Retrospective Study.
Topics: Ampicillin; Anti-Bacterial Agents; Brazil; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Retrospective Studies; Sulbactam; Urinary Tract Infections | 2016 |
Prevalence and antimicrobial susceptibility of Acinetobacter spp. isolated from meat.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Animals; Anti-Bacterial Agents; Cattle; Ceftazidime; Chickens; Ciprofloxacin; Cross Infection; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence; Red Meat; Sulbactam; Swine; Trimethoprim, Sulfamethoxazole Drug Combination | 2017 |
Life-Threatening Atypical Case of Acute Generalized Exanthematous Pustulosis.
Topics: Acute Generalized Exanthematous Pustulosis; Adult; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Enterococcus faecium; Humans; Male; Penicillin G; Periodontitis; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Systemic Inflammatory Response Syndrome | 2017 |
AmpC beta-lactamases in Klebsiella pneumoniae: An emerging threat to the paediatric patients.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefoperazone; Cefoxitin; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Cross-Sectional Studies; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Resistance, Bacterial; Female; Hospitals, Pediatric; Humans; Imipenem; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Pakistan; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2018 |
Community-Acquired Uropathogenic
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefazolin; Ciprofloxacin; Colistin; Cross-Sectional Studies; Cuba; Escherichia coli Proteins; Fosfomycin; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Sulbactam; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections; Uropathogenic Escherichia coli | 2022 |
Translation of Machine Learning-Based Prediction Algorithms to Personalised Empiric Antibiotic Selection: A Population-Based Cohort Study.
Topics: Aged; Algorithms; Ampicillin; Anti-Bacterial Agents; Cefepime; Ciprofloxacin; Cohort Studies; Female; Gentamicins; Humans; Imipenem; Machine Learning; Male; Middle Aged; Sulbactam; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections | 2023 |